Hospitals are facing “massive losses” treating patients with COVID-19––even with higher reimbursement for service, according to a new study from Strata Decision.

A health system that runs 23 hospitals has moved to restructure its debt, a move that will likely lead to its filing for Chapter 11 protection.

If three or more significant and similar occurrences signify a trend, the U.S. hospitals that have closed in the heat of the COVID-19 crisis—mostly rural institutions—may be harbingers of things to come.

CMS is allowing healthcare providers to react to the COVID-19 pandemic with greater flexibility by loosening some federal requirements and issuing sweeping new rules.

The heart of the matter is that more than 8,000 ventilators aren’t in hospitals to begin with. They’re in nursing homes.

At a time when mandatory immunization bills are pending in numerous states, more than enough chiropractors have organized against the norm to raise many eyebrows and considerable Cain.

If the group’s actions are successful against the three entities named, unions representing healthcare workers elsewhere in the U.S. may be incentivized to take their cases to the courts in similar fashion.

HHS is speeding up the development and manufacturing of COVID-19 vaccines by partnering with Johnson & Johnson-owned Janssen Research and Development and Moderna Therapeutics.

The altered landscape presents U.S. healthcare providers with an unavoidable question: What will our operations look like post COVID-19?

It’s been just about a year since Scott Gottlieb, MD, resigned as FDA commissioner. The COVID-19 crisis has drawn him back into the public eye. Could he become more influential now than ever?